(Q84580139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

proliferative glomerulonephritis

8 February 2020

main subject

1 reference

1 reference

2

Akira Shimizu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Yukinari Masuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mitue Kataoka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Takashi Arai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Arimi Ishikawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xuanyi Du

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sabine Kyoko Saito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Kaoru Aki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shinya Nagasaka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Akiko Mii

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Emiko Fujita

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yuh Fukuda

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

19 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1468-1481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20644521%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.130

8 February 2020

exact match

0 references

cites work

Role of glomerular endothelial damage in progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Contribution of the endothelium to the glomerular permselectivity barrier in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

The glomerular injury of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

VEGF(165) mediates glomerular endothelial repair

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Complement-mediated killing of mesangial cells in experimental glomerulonephritis: cell death by a combination of apoptosis and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Renal side effects of anti-VEGF therapy in man: a new test system.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

VEGF inhibition and renal thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Glomerular disease related to anti-VEGF therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Efficacy of vascular endothelial growth factor in the treatment of experimental gastric injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Intravenous immunoglobulin protects against experimental thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Peritubular capillary regression during the progression of experimental obstructive nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Hypertension and proteinuria: a class-effect of antiangiogenic therapies.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021

Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.130

7 January 2021